Methenamine Hippurate
9 NDCs across 9 manufacturers|9 Generic,0 Brand
Methenamine Hippurate is used to treat bacteriuria, cystitis, escherichia coli infections and staphylococcal infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jun 20, 2003. FDA's Orange Book lists 7 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $61 million on Methenamine Hippurate across 888,000 claims for 203,000 beneficiaries.
Methenamine Hippurate is available as 9 NDCs from 9 manufacturers (9 generic, 0 brand), with NADAC prices from $0.31 to $0.31 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
9
9G / 0B
Manufacturers
9
competing in market
Price Spread
$0.31 – $0.31
per EA
7d Activity
avg -0.3% WoW · of 9 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
9 manufacturers producing METHENAMINE HIPPURATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
METHENAMINE HIPP 1 GM TABLET | $0.3114 per EA | -0.29% |
METHENAMINE HIPP 1 GM TABLET | $0.3114 per EA | -0.29% |
METHENAMINE HIPP 1 GM TABLET | $0.3114 per EA | -0.29% |
METHENAMINE HIPP 1 GM TABLET | $0.3114 per EA | -0.29% |
METHENAMINE HIPP 1 GM TABLET | $0.3114 per EA | -0.29% |
METHENAMINE HIPP 1 GM TABLET | $0.3114 per EA | -0.29% |
METHENAMINE HIPP 1 GM TABLET | $0.3114 per EA | -0.29% |
METHENAMINE HIPP 1 GM TABLET | $0.3114 per EA | -0.29% |
METHENAMINE HIPP 1 GM TABLET | $0.3114 per EA | -0.29% |
Frequently Asked Questions
What is Methenamine Hippurate used to treat?
Methenamine Hippurate is used to treat bacteriuria, cystitis, escherichia coli infections and staphylococcal infections, per the National Library of Medicine's MED-RT classification.
When did Methenamine Hippurate become available as a generic?
FDA approved the first generic Methenamine Hippurate (ANDA) on Jun 20, 2003. The Orange Book currently lists 7 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Methenamine Hippurate?
In 2024, Medicare Part D spent $61 million on Methenamine Hippurate across 888,000 claims for 203,000 beneficiaries.
How many Methenamine Hippurate products are on the market?
The Methenamine Hippurate drug market contains 9 NDCs from 9 manufacturers — 9 generic and 0 brand products.
What is the price range for Methenamine Hippurate?
NADAC reference prices for Methenamine Hippurate range from $0.3114 to $0.3114 per EA.
Which manufacturers make Methenamine Hippurate?
9 manufacturers list Methenamine Hippurate in NADAC. Ranked by number of NDCs, the largest are Micro Labs Limited (1), Alvogen Inc. (1), AvPAK (1), Ingenus Pharmaceuticals LLC (1), Jubilant Cadista Pharmaceuticals Inc. (1).
How has the price of Methenamine Hippurate changed recently?
Over the past 7 days, 0 Methenamine Hippurate NDCs rose and 9 fell, with a market-wide average change of -0.3%.